The initiative aims to enhance production efficiency and reduce the risk of human error-induced inconsistencies.

SAN DIEGO, Oct. 17, 2024 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc., (Nasdaq: TVTX) and CSL Vifor today announced that Swissmedic has granted temporary marketing authorization for FILSPARI for the ...

An alliance with a German-based global operator promises further international expansion in the cell and gene therapies ...

Cellular Origins and Fresenius Kabi have partnered to integrate Fresenius Kabi's cell therapy processing tech with Cellular ...

On October 4, 2024, Amgen filed a BPCIA complaint in the District Court for the Northern District of Illinois Eastern Division against Fresenius ...

Only children and other patients with specific medical needs should start home peritoneal dialysis for the time being, the ...